Offer - Urjas Oil for just ₹ 1 X
Elipran 20 Tablet is a commercial drug that is prescribed in the form of Tablet. Migraine are some of its major therapeutic uses.
The correct dosage of Elipran 20 Tablet depends on the patient's age, gender, and medical history. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Detailed information has been provided in the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Elipran 20 Tablet as well, which are listed below. Such side effects of Elipran 20 Tablet normally do not last long and go away once the treatment is completed. However, if these continue for a longer time, consult your doctor right away.
In addition, Elipran 20 Tablet's effect is Moderate during pregnancy and Moderate for lactating mothers. Warnings related to Elipran 20 Tablet's effects on the liver, heart and kidney, if any, have been listed below.
Individuals suffering from medical conditions like Drug Allergy, Liver Disease, Heart Disease must refrain from the use of Elipran 20 Tablet since this can cause severe adverse effects. Other conditions have been mentioned below in the Elipran 20 Tablet contraindications section.
Besides this, Elipran 20 Tablet may also have severe interaction with some medicines. Refer to the list below for further details.
You should also be aware that Elipran 20 Tablet is not safe while driving, and is not addiction.
Elipran 20 Tablet is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Elipran 20 Tablet safe for pregnant women?
Elipran may cause moderate side effects during pregnancy. If you feel its harmful effects, then stop taking this drug immediately, and do not take Elipran again without your doctor's advice.
Is the use of Elipran 20 Tablet safe during breastfeeding?
Women who are breastfeeding can experience some moderate side effects of Elipran. Immediately discontinue Elipran if you observe any side effects. Contact your doctor, and restart using it only if your doctor considers it safe for you.
What is the effect of Elipran 20 Tablet on the Kidneys?
Elipran rarely harms the kidneys.
What is the effect of Elipran 20 Tablet on the Liver?
Elipran is rarely harmful for the liver.
What is the effect of Elipran 20 Tablet on the Heart?
Elipran may have mild side effects on the heart. Most people will never see any effect on the heart.
If you are suffering from any of the following diseases, you should not take Elipran 20 Tablet unless your doctor advises you to do so -
Is this Elipran 20 Tablet habit forming or addictive?
Forming a habit of Elipran 20 Tablet has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Elipran 20 Tablet can make you feel drowsy.
Is it safe?
Yes, Elipran 20 Tablet is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
Elipran 20 Tablet is unable to treat or cure mental disorders.
Interaction between Food and Elipran 20 Tablet
Due to a lack of research, nothing can be said about the consequences of taking Elipran 20 Tablet together with food.
Interaction between Alcohol and Elipran 20 Tablet
Information about the interaction of Elipran 20 Tablet and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Relpax® (eletriptan hydrobromide)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 91